Amid Growing Cold Chain Demand, GEODIS Opens First Dedicated Healthcare Cross-Dock Facility in Chicago

GEODIS, a global logistics provider and subsidiary of SNCF Group, has launched its first dedicated healthcare cold chain cross-dock facility in the Americas, marking an expansion of temperature-controlled infrastructure for pharmaceutical and life sciences shipments in the United States.

The 78,000-square-foot Container Freight Station (CFS) and bonded facility in Chicago, Illinois, includes a newly constructed 5,200-square-foot temperature-controlled addition designed specifically for healthcare cargo. Positioned near O’Hare International Airport, the site functions as a high-velocity node within GEODIS’ global freight forwarding network, supporting both air and ocean pharmaceutical imports and exports.¹

Why Was Chicago Selected?

According to the company, Chicago was selected due to its role as one of the most active freight gateways in North America, with extensive air cargo connectivity and multimodal access to national distribution corridors. As a bonded CFS facility, the site enables streamlined customs handling while maintaining secure short-term stowage for healthcare products in transit.¹

The facility also extends GEODIS’ ability to maintain internal control over temperature-sensitive cargo across its global network spanning nearly 170 countries. For pharmaceutical shipments, this end-to-end visibility is increasingly important as regulators and manufacturers place greater emphasis on chain-of-custody documentation and real-time environmental monitoring.

What Does the Chicago Site Feature?

The Chicago site includes two distinct temperature-controlled zones tailored to pharmaceutical handling requirements. The first zone spans 4,600 square feet and is designed for controlled ambient storage between 15°C and 25°C, with 27 feet of clear ceiling height to accommodate palletized air freight and ocean containers.¹ The second zone provides 600 square feet of refrigerated storage maintained between 2°C and 8°C, a critical range for many biologics, vaccines, and specialty pharmaceuticals.¹

These capabilities allow the facility to manage a broad spectrum of temperature-sensitive healthcare products, including those requiring strict excursion control during cross-docking and transfer between air and ocean modalities. The Chicago branch is also a Certified Cargo Screening Facility and holds IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics certification. This designation is widely recognized across the industry as a benchmark for pharmaceutical handling.

Why Is there Growing Demand for Cold Chain Infrastructure?

The investment comes as demand for temperature-controlled logistics continues to accelerate, driven by growth in biologics, cell and gene therapies, and global vaccine distribution. Industry analyses suggest that the global pharmaceutical cold chain logistics market is projected to surpass $30 billion by 2035.²Cold chain logistics is no longer a peripheral function but a core enabler of product integrity and regulatory compliance. As product portfolios become more temperature-sensitive, the margin for logistical error continues to narrow.

“The opening of our first dedicated healthcare cold chain cross-dock in the U.S. demonstrates our commitment to the integrity and efficacy of the life-saving products we handle,” said Josh Jungwirth, executive vice president of freight forwarding at GEODIS in the Americas. “By providing full visibility and internal control within our growing network of certified sites, we ensure that these sensitive air and ocean shipments are protected every step of the way.”¹

The expansion of integrated cold chain cross-dock infrastructure in major US gateways signals continued consolidation of control points within logistics networks. Facilities that combine bonded status, CEIV Pharma certification, and temperature-controlled handling are increasingly positioned as critical infrastructure for maintaining compliance and reducing product risk during transfer-heavy segments of the supply chain.

GEODIS’ expansion also reinforces Chicago’s role as a strategic hub for life sciences logistics, particularly as demand for rapid, compliant distribution of high-value therapeutics continues to grow across North America and global export markets.

References

1. GEODIS. GEODIS unveils first cold chain cross-dock facility in the Americas. GEODIS. Published April 22, 2026. Accessed April 22, 2026. https://geodis.com/us-en/newsroom/geodis-unveils-first-cold-chain-cross-dock-facility-americas

2.Kumbhar T. Cold chain pharmaceuticals market is projected to reach USD 31.02 billion by 2035. Introspective Market Research. Published January 2026. Accessed April 22, 2026. https://introspectivemarketresearch.com/press-release/cold-chain-pharmaceuticals-market/